Browsing publications by Dr David Kavanagh

Newcastle AuthorsTitleYearFull text
Professor Neil Sheerin
Dr David Kavanagh
Professor Tim Goodship
Dr Sally Johnson
A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience2016
Dr David Kavanagh
Dr Kate Smith-Jackson
Eculizumab in children with hemolytic uremic syndrome2016
Dr Vicky Brocklebank
Dr Edwin Wong
Dr Kevin Marchbank
Professor Tim Goodship
Dr David Kavanagh
et al.
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies2016
Rachel Challis
Dr Edwin Wong
Dr Holly Anderson
Dr Valerie Wilson
Dr Vicky Brocklebank
et al.
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrome2015
Dr Edwin Wong
Dr David Kavanagh
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome2015
Dr Veronique Fremaux-Bacchi
Professor Tim Goodship
Dr David Kavanagh
Atypical aHUS: State of the art2015
Rachael Watson
Dr Karim Bennaceur
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
et al.
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)2015
Dr Edwin Wong
Dr Vicky Brocklebank
Professor Tim Goodship
Dr David Kavanagh
Dr Anna Richards
et al.
Characterisation of a C3 Mutation with Increased Resistance to Complement Regulation in an Individual with Recurrent C3GN in a Renel Transplant2015
Dr Edwin Wong
Rachel Challis
Professor Neil Sheerin
Dr Sally Johnson
Dr David Kavanagh
et al.
Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS)2015
Dr David Kavanagh
Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels2015
12345678